Illumina Q3 earnings beat estimates, prompting Cwm LLC to boost its stake by 43.9%. Discover why analysts maintain a 'Hold' ...

Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...

The Dow eased 0.1% despite Nvidia NVDA picking up momentum with a gain of nearly 2% in recent action. McDonald's MCD and ...

Tempus AI’s TEM reimbursement showed modest sequential improvement in the third quarter of 2025, though average blended ...

Illumina (ILMN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in ...

In a report released today, from Jefferies maintained a Hold rating on Illumina, with a price target of $125.00. In addition to Jefferies, Illumina also received a Hold from J.P. Morgan’s Casey ...

In a report released today, Luke Sergott from Barclays maintained a Sell rating on Illumina, with a price target of $110.00. Sergott covers the Healthcare sector, focusing on stocks such as Illumina, ...

UDPATED: Netflix’s stock was up and down in trading Friday after the company announced a debt-fueled deal to acquire Warner Bros. Discovery’s studios and HBO Max streamer — while investors pushed WBD ...

Costco Wholesale Corporation (COST) posted another consistent month of comparable sales growth in November despite concerns around consumer spending, the government shutdown, and a reduction in SNAP ...

Illumina (ILMN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.